Stay updated on CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.

Latest updates to the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedMultiple myeloma has been added as a topic, and MedlinePlus Genetics is now listed under related topics. The page revision has been updated from v3.6.4 to v3.6.5.SummaryDifference0.2%

- Check21 days agoChange DetectedExplicit disease term 'Multiple myeloma' is removed from the study details, and the related topics section including the MedlinePlus Genetics link is deleted. This changes how users identify the study focus and locate related information.SummaryDifference0.2%

- Check28 days agoChange DetectedThe study page now includes 'Multiple myeloma' as a listed condition and adds a Related Topics reference to MedlinePlus Genetics. The site footer revision tag has been updated to v3.6.4, replacing the previous v3.6.3.SummaryDifference0.2%

- Check49 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 in the page header, indicating a small platform update to ClinicalTrials.gov. This change does not alter study details or other visible content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a small patch to the page or underlying system. No study data or navigation elements appear to be modified.SummaryDifference0.1%

- Check63 days agoChange DetectedThe primary condition label 'Multiple myeloma' and the related topics section (including MedlinePlus Genetics) were removed from the page. This changes what the page presents about the study’s condition and the available educational links.SummaryDifference0.2%

Stay in the know with updates to CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.